A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
Yasmin Abo‐zeid, Nasser S. M. Ismail, Gary R. McLean, Nadia Μ. Hamdy
Topics & Concepts
RepurposingCoronavirus disease 2019 (COVID-19)VirologyDocking (animal)Drug repositioningDrugEquine infectious anemiaVirusHepatitis C virusGlycoproteinPharmacologyChemistryMedicineInfectious disease (medical specialty)BiologyDiseaseBiochemistryNursingEcologyPathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing